Analysis of TGCA data reveals genetic and epigenetic changes and biological function of MUC family genes in colorectal cancer

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Ferlay J, Soerjomatarm I, Dikshit R et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 136(5), E359–E386 (2015).
  Medline CASGoogle Scholar
• 2. Fagunwa IO, Loughrey MB, Coleman HG. Alcohol, smoking and the risk of premalignant and malignant colorectal neoplasms. Best Pract. Res. Clin. Gastroenterol. 31(5), 561–568 (2017).
  MedlineGoogle Scholar
• 3. Boada LD, Henríquez-Hernández LA, Luzardo OP. The impact of red and processed meat consumption on cancer and other health outcomes: epidemiological evidences. Food Chem. Toxicol. 92, 236–244 (2016).
  Medline CASGoogle Scholar
• 4. Brevik A, Joshi AD, Corral R, Onland-Moret NC et al. Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epi. Prev. Biomarkers 19(12), 3167–3173 (2010).
  Medline CASGoogle Scholar
• 5. de Voer RM, van Kessel AG, Weren RD et al. Germline mutations in the spindle assembly checkpoint genes BUB1 and BUB3 are risk factors for colorectal cancer. Gastroenterology 145(3), 544–547 (2013).
  Medline CASGoogle Scholar
• 6. Kambara T, Simms LA, Whitehall V et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53(8), 1137–1144 (2004).
  Medline CASGoogle Scholar
• 7. Imai Y, Yamagishi H, Fukuda K et al. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma. World J. Gastroenterol. 19(25), 3957 (2013).
  MedlineGoogle Scholar
• 8. Boltin D, Perets TT, Vilkin A et al. Mucin function in inflammatory bowel disease: an update. J. Clin. Gastroenterol. 47(2), 106–111 (2013).
  Medline CASGoogle Scholar
• 9. Bhatia R, Gautam SK, Cannon A et al. Cancer-associated mucins: role in immune modulation and metastasis. Cancer Metast. Rev. 38(1–2), 223–236 (2019).
  Medline CASGoogle Scholar
• 10. Shanmugam C, Jhala NC, Katkoori VR et al. Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer 116(15), 3577–3586 (2010).
  Medline CASGoogle Scholar
• 11. Soliman BG, Karagkounis G, Church JM et al. Mucinous histology signifies poor oncologic outcome in young patients with colorectal cancer. Dis. Colon Rectum 61(5), 547–553 (2018). • Indicates that mucinous histology is a negative prognostic factor in young patients with colorectal cancer (CRC).
  MedlineGoogle Scholar
• 12. Ham SY, Kwon T, Bak Y et al. Mucin 1-mediated chemo-resistance in lung cancer cells. Oocogenesis 5(1), e185 (2016).
  Medline CASGoogle Scholar
• 13. Takahashi H, Jin C, Rajabi H et al. MUC1-C activates the TAK1 inflammatory pathway in colon cancer. Oncogene 34(40), 5187 (2015).
  Medline CASGoogle Scholar
• 14. Gupta B, Das P, Ghosh S et al. Identification of high-risk aberrant crypt foci and mucin-depleted foci in the human colon with study of colon cancer stem cell markers. Clin. Colorectal Cancer 16(3), 204–213 (2017).
  MedlineGoogle Scholar
• 15. Lahdaoui F, Messager M, Vincent A et al. Depletion of MUC5B mucin in gastrointestinal cancer cells alters their tumorigenic properties: implication of the Wnt/β-catenin pathway. Biochem. J. 474(22), 3733–3746 (2017).
  Medline CASGoogle Scholar
• 16. Thériault C, Pinard M, Comamala M et al. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol. Oncol. 121(3), 434–443 (2011).
  Medline CASGoogle Scholar
• 17. Sanchez-Vega F, Mina M, Armenia J et al. Oncogenic signaling pathways in the cancer genome atlas. Cell 73(2), 321–337 (2018).
  Google Scholar
• 18. Ritchie ME, Phipson B, Wu D et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43(7), e47 (2015).
  MedlineGoogle Scholar
• 19. Ha G, Shah S. Distinguishing somatic and germline copy number events in cancer patient DNA hybridized to whole-genome SNP genotyping arrays. Methods Mol. Biol. 973, 355–372 (2013). • Provides a clue on how to analysed whole-genome cancer DNA hybridized to single nucleotide polymorphism genotyping arrays focusing on distinguishing somatic CAN, germline copy number variants.
  Medline CASGoogle Scholar
• 20. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat. Med. 9(7), 811–818 (1990).
  Medline CASGoogle Scholar
• 21. Hinoue T, Weisenberger DJ, Lange CP et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res. 22(2), 271–282 (2012). • Provides an evidence that distinct genetic and epigenetic alterations were observed in CRC.
  Medline CASGoogle Scholar
• 22. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9(1), 559 (2008).
  MedlineGoogle Scholar
• 23. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. 4(1), 1–43 (2005).
  CASGoogle Scholar
• 24. Johansson ME, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nat. Rev. Immunol. 16(10), 639 (2016). •• Tells us that mucins play an important role in immune regulation in the intestine.
  Medline CASGoogle Scholar
• 25. Sheng YH, Lourie R, Lindén SK et al. The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut 60(12), 1661–1670 (2011).
  Medline CASGoogle Scholar
• 26. Gupta BK, Maher DM, Ebeling MC et al. Functions and regulation of MUC13 mucin in colon cancer cells. J. Gastroenterol. 49(10), 1378–1391 (2014).
  Medline CASGoogle Scholar
• 27. van der Sluis M, de Koning BA, de Bruijn AC et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131(1), 117–129 (2006).
  MedlineGoogle Scholar
• 28. Betge J, Schneider NI, Harbaum L et al. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. Virchows Arch. 469(3), 255–265 (2016). •• Shows that several members of MUC family were associated with favorable outcome in CRC.
  Medline CASGoogle Scholar
• 29. Hattrup CL, Gendler SJ. Structure and function of the cell surface (tethered) mucins. Annu. Rev. Physiol. 70, 431–457 (2008).
  Medline CASGoogle Scholar
• 30. Jonckheere N, Van Seuningen I. Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas. J. Transl. Med. 16(1), 259 (2018). • Suggests that several members of MUC family act as markers of poor prognostic for pancreatic, colon and stomach cancers.
  MedlineGoogle Scholar
• 31. Haridas D, Chakraborty S, Ponnusamy MP et al. Pathobiological implications of MUC16 expression in pancreatic cancer. PLoS ONE 6(10), e26839 (2011).
  Medline CASGoogle Scholar
• 32. Li X, Pasche B, Zhang W et al. Association of MUC16 mutation with tumor mutation load and outcomes in patients with gastric cancer. JAMA Oncol. 4(12), 1691–1698 (2018). • Another evidence of mucins as guidance in immunotherapy treatment.
  MedlineGoogle Scholar
• 33. Albrecht H, Carraway III KL. MUC1 and MUC4: switching the emphasis from large to small. Cancer Biother. Radiopharm. 26(3), 61–271 (2011).
  Google Scholar
• 34. Shanmugam C, Jhala NC, Katkoori VR et al. Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer 116(15), 3577–3586 (2010).
  Medline CASGoogle Scholar
• 35. Wang W, Chen J, Zhao F et al. MiR-150-5p suppresses colorectal cancer cell migration and invasion through targeting MUC4. Asian Pac. J. Cancer Prev. 15(15), 6269–6273 (2014).
  MedlineGoogle Scholar
• 36. Peng QL, Ren J, Yan XM et al. The g. 243A> G mutation in intron 17 of MUC4 is significantly associated with susceptibility/resistance to ETEC F4ab/ac infection in pigs. Anim. Genet. 38(4), 397–400 (2007).
  Medline CASGoogle Scholar
• 37. Okudaira K, Kakar S, Cun L et al. MUC2 gene promoter methylation in mucinous and non-mucinous colorectal cancer tissues. Int. J. Oncol. 36(4), 765–775 (2010). • Indicates that MUC2 expression and mucin contents were negatively related with methylation status.
  Medline CASGoogle Scholar
• 38. Tang J, Zhang L, She X et al. Inhibiting CD164 expression in colon cancer cell line HCT116 leads to reduced cancer cell proliferation, mobility, and metastasis in vitro and in vivo. Cancer Invest. 30(5), 380–389 (2012).
  Medline CASGoogle Scholar
• 39. McManus S, Chababi W, Arsenault D et al. Dissecting oncogenic RTK pathways in colorectal cancer initiation and progression. Methods Mol. Biol. 1765, 27–42 (2018).
  Medline CASGoogle Scholar
• 40. Masliah-Planchon J, Garinet S, Pasmant E. RAS-MAPK pathway epigenetic activation in cancer: miRNAs in action. Oncotarget 7(25), 38892 (2016).
  MedlineGoogle Scholar
• 41. Dubois F, Leroy C, Simon V et al. YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells. Am. J. Cancer Res. 5(6), 1972 (2015).
  Medline CASGoogle Scholar
• 42. Jiang H, Wang Y, Ai M et al. Long noncoding RNA CRNDE stabilized by hnRNPUL2 accelerates cell proliferation and migration in colorectal carcinoma via activating Ras/MAPK signaling pathways. Cell Death Dis. 8(6), e2862 (2017).
  Medline CASGoogle Scholar
• 43. Yokoyama S, Higashi M, Tsutsumida H et al. TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer. Genes Cancer 8(3–4), 517 (2017).
  Medline CASGoogle Scholar
• 44. Cho JS, Park MH, Lee JS et al. Reduced MUC4 expression is a late event in breast carcinogenesis and is correlated with increased infiltration of immune cells as well as promoter hypermethylation in invasive breast carcinoma. Appl. Immunohisto. Mol. Morphol. 23(1), 44–53 (2015).
  CASGoogle Scholar